Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: Case report (original) (raw)

ANTIPSYCHOTIC TREATMENT AND WEIGHT GAIN: DOES RISPERIDONE BEHAVE DIFFERENTLY IN PAKISTANI PSYCHIATRIC PATIENTS?

J Ayub Med Coll Abbottabad, 2010

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study

Gabriela Hernandez

Schizophrenia Research, 2003

View PDFchevron_right

A typical Antipsychotic Induced Weight Gain: Pathophysiology and Management

Sarath Gunatilake

Annals of Clinical Psychiatry, 2004

View PDFchevron_right

Increasing Energy Expenditure Is Important to Enhance Management of Antipsychotic-Associated Weight Gain

Andrew Hills

The Journal of Clinical Psychiatry, 2005

View PDFchevron_right

Atypical Antipsychotic Induced Weight Gain in Schizophrenic Patients

tetie herlina

Indonesian Journal of Clinical Pharmacy, 2021

View PDFchevron_right

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis

Julia Vakhrusheva

Neuropsychopharmacology, 2010

View PDFchevron_right

Weight gain from novel antipsychotic drugs: need for action

R. Goisman

General Hospital Psychiatry, 2000

View PDFchevron_right

2848 – Second generation antipsychotic-induced weight alteration

Maria de Lourdes Rabelo Pequeno

European Psychiatry, 2013

View PDFchevron_right

Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study

Michael Bloch

Journal of Child and Adolescent Psychopharmacology, 2018

View PDFchevron_right

Weight gain and antipsychotics. Data from EUFEST study

Valentin Matei, Traian Purnichi

View PDFchevron_right

Body weight gain induced by antipsychotic drugs: mechanisms and management

Trino Baptista

Acta Psychiatrica Scandinavica, 1999

View PDFchevron_right

Antipsychotic Medications and Weight Gain: Etiologies, Predictors and Adverse Clinical Consequences

Saud Alsanad

International Neuropsychiatric Disease Journal, 2018

View PDFchevron_right

Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis

Takefumi Suzuki

Schizophrenia Bulletin, 2014

View PDFchevron_right

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment

Ilona Gorbovskaya

Frontiers in neuroscience, 2017

View PDFchevron_right

Antipsychotic-Induced Weight Gain and Metabolic Side Effects: Underlying Mechanisms, Monitoring, and Pharmacological Intervention/Prevention Strategies

Michael Davidson

Child and Adolescent Psychopharmacology News, 2010

View PDFchevron_right

Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder

영준 신

The Journal of Clinical Psychiatry, 2006

View PDFchevron_right

Clinical and Biological Perspectives of Non-antipsychotic Psychotropic Medications and Weight Gain

Dr.Naseem Qureshi

International Neuropsychiatric Disease Journal

View PDFchevron_right

Behavioural management of antipsychotic-induced weight gain: a review

U. Werneke

Acta Psychiatrica Scandinavica, 2003

View PDFchevron_right

Pharmacological Add-On Treatments in Managing Antipsychotic-Induced Weight Gain

Codrina Moraru

The European Conference of Psychiatry and Mental Health "Galatia"

View PDFchevron_right

Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia

Peter Weiden

The Journal of clinical psychiatry, 2007

View PDFchevron_right

Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder

LESLIE CITROME

Clinical Drug Investigation, 2011

View PDFchevron_right

Weight gain associated with atypical antipsychotic drugs: mechanisms and management

Sarath Gunatilake

Expert Review of Neurotherapeutics, 2003

View PDFchevron_right

A 6 week prospective randomized comparative study of metabolic adverse effects of Risperidone and Iloperidone in patients with schizophrenia

IP Innovative Publication Pvt. Ltd.

View PDFchevron_right

Metabolic Disturbances Associated with Atypical Antipsychotics

Michel Bourin

JURNALUL ROMÂN DE …

View PDFchevron_right

Serge Beaulieu

Pharmacopsychiatry, 2002

View PDFchevron_right

Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

Rohan Ganguli

Schizophrenia Research, 2001

View PDFchevron_right

The metabolic effects of antipsychotic medications

John Newcomer

Canadian Journal of Psychiatry Revue Canadienne De Psychiatrie, 2006

View PDFchevron_right

The Effects of Antipsychotic Drugs (Olanzapine and Risperidone) on Body Weight, Body Fat Percentage and Lipid Profiles of Patients with Psychotic Illness

Geo George

Borneo Journal of Medical Sciences (BJMS), 2019

View PDFchevron_right

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human

Tomas Mow

Pharmacology Biochemistry and Behavior, 2003

View PDFchevron_right

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis

Jouke Janssen, Maarten Bak

PLoS ONE, 2014

View PDFchevron_right

Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: Case report (original) (raw)

Related papers